At a glance
ClinicalIndex Comparison RecordN/ACompleted· 360 enrolled
Drug / intervention
D2Odevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Study for the Validation of the BC3 Bioelectrical Impedance Hydration Factor
In Brief
A clinical study evaluating D2O for Body Composition. Completed, enrolled 360 participants across 1 site.
Detailed Summary
This was a pilot study to validate the BC3 hydration factor which will be important for determining how well this value represents hydration status compared to assessment of total body water by D20.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBody Composition
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2009
Primary CompletionJun 2010
Study CompletionJul 2010
First PostedSep 2010
TodayJul 2026
First PostedSep 27, 2010
Enrollment StartSep 1, 2009
Primary CompletionJun 1, 2010
Study CompletionJul 1, 2010
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 15.8 years ago
Interventions
D2Odevice
All participants received deuterium oxide (D2O) and testing with the BC3 for the measurement of total body water.